Skip to main content

Table 1 Baseline characteristics of the study cohort (n = 543).

From: Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study

Variable (unit) N Median or percent 2.5th Percentile 97.5th Percentile
Age (years) 543 68.8 24.2 92.7
Sex     
   Male 252 46.4 % - -
   Female 291 53.6 % - -
Baseline diagnosis     
   Symptoms, signs or for observationa 126 23.2 % - -
   Respiratory disease 112 20.6 % - -
   Cardiovascular disease 88 16.2 % - -
   Endocrine disease 43 7.9 % - -
   Infectious diseaseb 36 6.6 % - -
   Hematological disease 26 4.8 % - -
   Other 112 20.6 % - -
Charlson Score     
0 342 63.0 % - -
1 152 28.0 % - -
2 35 6.45 % - -
3 9 1.66 % - -
4+ 5 0.92 % - -
SuPAR (ng/ml) 543 4.28 1.81 13.6
Creatinine (μmol/l) 541 76.0 42.0 215
CRP (mg/l) 540 8.00 1.00 286
Leukocytes (109/l) 539 8.30 3.60 22.9
ALAT (U/l) 541 22.0 8.00 120
Albumin (g/l) 538 35.0 22.0 43.0
Hemoglobin (mmol/l) 541 7.90 5.00 9.90
  1. aICD-10 Chapter XVIII diagnoses (R00-R99) and Chapter XXI diagnoses (Z00-Z99) collapsed; bICD-10 Chapter I diagnoses (A00-B99). Some values were missing for biomarkers other than suPAR (samples failed because of hemolysis or because they were lost).